http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201235037-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_028dcc2f3d757188503f5b930c51bfc0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 |
| filingDate | 2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0df9f52e9a62ce9cfc90937c8877c1 |
| publicationDate | 2012-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201235037-A |
| titleOfInvention | Sensitizer, pharmaceutical composition, kit and use for target therapy |
| abstract | A target therapy sensitizer is disclosed. The target therapy sensitizer includes rapamycin and substituted quinoline. The present invention discloses a pharmaceutical composition containing the sensitizer, a target therapy sensitization kit containing the two aforementioned compounds and a use of a combination of the two aforementioned compounds as a target therapy sensitizer as well. The application of the target therapy sensitizer, pharmaceutical composition, kit and use of the present invention is advantageous for improving the treatment effect of target therapies. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I707681-B |
| priorityDate | 2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.